On November 17, Wu Jun, the director of the Chuzhou Market Supervision Administration, conducted an in-depth investigation of Anhui Tiankang Medical Technology Co., LTD. The investigation focuses on the company's operating conditions under the current market situation, the practical difficulties, the output value of company and the research and development of company investment.

Director Wu Jun firstly visited the production workshop, and expressed a high degree of recognition for the company's production line and product quality management. Then a seminar was held by Director Wu Jun and the company's senior management. At the seminar, Director Wu Jun expressed a full understanding of the company's market performance and development momentum, and gave expectations and encouragement to the development of the company. 

The representatives of Anhui Tiankang Medical Technology Co., LTD. introduced the company's current market situation in detail, including the market share of various products, the sales data and the expansion plans for the future market. In view of the practical difficulties at present, such as the rising costs of raw material, the increasingly fierce of market competition and other issues, the person in charge of Anhui Tiankang Medical Technology Co., LTD. also engaged in a candid exchange of views, and explained to Director Wu Jun the response measures being taken by the company. 

In terms of the company's total output value and R&D investment, Anhui Tiankang Medical Technology Co., LTD. showed its steady growth in the medical device industry, and introduced emphatically the company's achievements in new products. In the field of research and development, the company has numbers of independent intellectual property rights and patented technologies, which has been highly admired by Director Wu Jun. 

In addition, export qualification is also the core content of this research. With the expansion of the international market, Anhui Tiankang Medical Technology Co., LTD. has obtained numbers of export qualification certifications, enabling the company to better participate in international competition and explore overseas market.

At the end of the investigation, Director Wu Jun put forward his own suggestions for the future development of the company, and said that the Market Supervision Administration will support the development of the company as always, and help to solve the problems encountered in the production and operation of the company.

Through this investigation, a good communication bridge has been established between Chuzhou Market Supervision Administration and Anhui Tiankang Medical Technology Co., LTD., which has made beneficial exploration and contribution to the development of the medical industry in Chuzhou .